Rong-Nan Chien (Rong N Chien)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Topics

Hepatitis C Virus

Ulcerative Colitis

Helicobacter Pylori

Top Venues

Scientific reports

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kang-Wei Peng, Ming-Ling Chang, Rong-Nan Chien, Yung-Chang Chen, Ya-Chung Tian, Yun-Shing Peng, Hui-Chun Huang, Ji-Tseng Fang, Fa-Yauh Lee, Chih-Wei Yang, Ming-Hung Tsai
Pulmonary Vascular Permeability and Extravascular Lung Water Index in Patients with Liver Cirrhosis and Septic Shock. Journal of clinical medicine 13 (13) (2024)
Kang-Wei Peng, Ming-Ling Chang, Rong-Nan Chien, Yung-Chang Chen, Ya-Chung Tian, Yun-Shing Peng, Hui-Chun Huang, Ji-Tseng Fang, Fa-Yauh Lee, Chih-Wei Yang, Ming-Hung Tsai
Pulmonary Vascular Permeability and Extravascular Lung Water Index in Patients with Liver Cirrhosis and Septic Shock. Journal of clinical medicine 13 (13) (2024)
Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival. Hepatology (Baltimore, Md.) (2024)
Rong-Nan Chien, Sheng-Nan Lu, Grace Hui-Min Wu, Wen-Wen Yang, Raoh-Fang Pwu, Chia-Ling Liu, Kuo-Pen Cheng, Shih-Chung Chen, Chien-Jen Chen
Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan. The Journal of infectious diseases 228 (Supplement_3) (2023)
Rong-Nan Chien
State-of-the-Art Chronic Hepatitis Viruses Research in Asia. Viruses 15 (5) (2023)
Chih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, Chau-Ting Yeh
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers 15 (13) (2023)
Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) 79 (5) (2023)
Tsung-Hsing Chen, Hung-Chih Hsu, Jeng-Fu You, Cheng-Chou Lai, Yung-Kuan Tsou, Chia-Lin Hsu, Cathy S J Fann, Rong-Nan Chien, Ming-Ling Chang
Extracellular Nicotinamide Phosphoribosyltransferase as a Surrogate Marker of Prominent Malignant Potential in Colonic Polyps: A 2-Year Prospective Study. Cancers 15 (6) (2023)
Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) (2023)
Yen-Chun Liu, Wen-Juei Jeng, Rong-Nan Chien
Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection. Alimentary pharmacology & therapeutics 58 (7) (2023)
Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) 79 (5) (2023)
Tsung-Hsing Chen, Hung-Chih Hsu, Jeng-Fu You, Cheng-Chou Lai, Yung-Kuan Tsou, Chia-Lin Hsu, Cathy S J Fann, Rong-Nan Chien, Ming-Ling Chang
Extracellular Nicotinamide Phosphoribosyltransferase as a Surrogate Marker of Prominent Malignant Potential in Colonic Polyps: A 2-Year Prospective Study. Cancers 15 (6) (2023)
Wen-Juei Jeng, Rong-Nan Chien
Unsolved issues in treatment for grey zone chronic hepatitis B patients. Hepatology international 16 (4) (2022)
Ming-Ling Chang, Rong-Nan Chien, Yun-Fan Liaw
Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof-of-concept study. Hepatology research : the official journal of the Japan Society of Hepatology 52 (10) (2022)
Yi-Tse Su, Ming-Ling Chang, Rong-Nan Chien, Yun-Fan Liaw
Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies. Viruses 14 (9) (2022)
Cheng-Er Hsu, Yen-Chun Liu, Ya-Ting Cheng, Wen-Juei Jeng, Rong-Nan Chien, Yung-Chang Lin, Dar-In Tai, I-Shyan Sheen
Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals. Viruses 14 (4) (2022)
Rong-Nan Chien, Yun-Fan Liaw
Current Trend in Antiviral Therapy for Chronic Hepatitis B. Viruses 14 (2) (2022)
Paul Wei-Che Hsu, Po-Cheng Liao, Yu-Hsiang Kao, Xin-Yu Lin, Rong-Nan Chien, Chau-Ting Yeh, Chi-Chun Lai, Yu-Chiau Shyu, Chih-Lang Lin
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese Population. International journal of molecular sciences 23 (20) (2022)
Li-Wei Chen, Cheng-Hung Chien, Chih-Lang Lin, Rong-Nan Chien
Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study. Journal of personalized medicine 11 (10) (2021)
Ching Chang, Chien-Hao Huang, Hsiao-Jung Tseng, Fang-Chen Yang, Rong-Nan Chien
Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan. Journal of personalized medicine 11 (6) (2021)
Li-Wei Chen, Liang-Che Chang, Chung-Ching Hua, Ching-Jung Liu, Tien-Shin Chou, Chih-Lang Lin, Rong-Nan Chien
The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial. Journal of clinical medicine 10 (19) (2021)
Sherry Yueh-Hsia Chiu, Kuo-Chin Chang, Tsung-Hui Hu, Rong-Nan Chien
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply. Alimentary pharmacology & therapeutics 53 (9) (2021)
Tsung-Hui Hu, Sherry Yueh-Hsia Chiu, Po-Lin Tseng, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Ming-Tsung Lin, Kuo-Chin Chang, Meng-Chih Lin, Rong-Nan Chien
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Chris Estes, Henry Lik Yuen Chan, Rong-Nan Chien, Wan-Long Chuang, James Yan-Yue Fung, George Boon-Bee Goh, Tsung-Hui Hu, Jee-Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia-Horng Kao, Young-Joo Jin, Han-Chieh Lin, Kathryn Razavi-Shearer, Wai Kay Seto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Homie Razavi
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Chun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, Yung-Chang Lin, Tsung-Hui Hu, Shui-Yi Tung, Sen-Yung Hsieh, Sheng-Nan Lu, Rong-Nan Chien, Chao-Hung Hung, I-Shyan Sheen
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis. Scientific reports 9 (1) (2019)
Li-Wei Chen, Sheng-Fong Kuo, Chih-Hung Chen, Cheng-Hung Chien, Chih-Lang Lin, Rong-Nan Chien
A community-based study on the association between Helicobacter pylori Infection and obesity. Scientific reports 8 (1) (2018)
Kung-Hao Liang, Sang Hoon Ahn, Hye Wong Lee, Ya-Hui Huang, Rong-Nan Chien, Tsung-Hui Hu, Kwang-Huei Lin, Christopher Sung-Huan Yeh, Chao-Wei Hsu, Chih-Lang Lin, Tai-Long Pan, Po-Yuan Ke, Ming-Ling Chang, Chau-Ting Yeh
A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study. Scientific reports 8 (1) (2018)
Ching-Chih Hu, Wen-Juei Jeng, Yi-Cheng Chen, Jian-He Fang, Chien-Hao Huang, Wei Teng, Yi-Chung Hsieh, Yung-Chang Lin, Rong-Nan Chien, I-Shyan Sheen, Yung-Chang Lin
Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction. Scientific reports 7 (1) (2017)